ASNC, AMA fight AI use to deny prior authorizations | FDA recall of bypass cannula | First patient gets HF LV reducer

Suman Tandon, MD, a representative of the American Society of Nuclear Cardiology, explains her organization's concerns about artificial intelligence being used to automatically deny prior authorizations and prevent patients from accessing care.

The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.

The news is related to an earlier recall of more than 316,000 Medtronic devices.

After being ordered to pay $442 million in damages—a ruling the company has said it may appeal—Johnson & Johnson MedTech is now facing the possibility of a permanent injunction that could impact certain business practices. A hearing is scheduled for July. 

The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions. 

RSNA and several other industry societies have shared a new expert consensus document on the significant value of cardiac CT. Echo remains an effective first-line imaging option, the groups wrote, but CT can make a big impact as well. 

The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use. 

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

The designation was awarded to a research team from China, who analyzed the efficacy of a novel radiotracer developed to target expression of the PD-L1 protein in suspected head and neck cancers. 

The opportunistic screening helps identify patients in need of monitoring and/or intervention without disrupting workflows.

A class-action lawsuit claims CVS Health sent text messages to customers and patients, inciting fear over a PBM regulation up for vote in Louisiana. Plaintiffs allege the incident violates state data privacy and political communication laws.

A “sophisticated cybercrime group” is being blamed for an attack on the network of the private insurer, which may have exposed social security numbers and protected health information. The incident is still being investigated.

These images were taken at the 2025 American Medical Association (AMA) House of Delegates (HOD) meeting in Chicago. This annual meeting brings together representatives from across the House of Medicine to propose, debate and vote on resolutions that shape AMA policy. Once adopted, these resolutions guide the group's advocacy efforts on healthcare issues—whether in Congress, state legislatures or in formal recommendations to regulatory agencies.

ACR and 10 other medical societies filed a “friend of the court” brief in an ongoing lawsuit against the National Institutes of Health, HHS and their leaders.